Zoekresultaten - Reuter, Uwe
- Toon 1 - 20 resultaten van 58
- Ga naar de volgende pagina
-
1
-
2
-
3
5-HT(1F) receptor agonists: A new treatment option for migraine attacks? door Neeb, Lars, Meents, Jannis, Reuter, Uwe
Gepubliceerd in 2010Text -
4
Coley’s Lessons Remembered: Augmenting Mistletoe Therapy door Orange, Maurice, Reuter, Uwe, Hobohm, Uwe
Gepubliceerd in 2016Text -
5
-
6
Weather sensitivity in migraineurs door Hoffmann, Jan, Lo, Hendra, Neeb, Lars, Martus, Peter, Reuter, Uwe
Gepubliceerd in 2010Text -
7
-
8
-
9
-
10
-
11
-
12
The potential of lasmiditan in migraine door Mecklenburg, Jasper, Raffaelli, Bianca, Neeb, Lars, Sanchez del Rio, Margarita, Reuter, Uwe
Gepubliceerd in 2020Text -
13
-
14
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis door Overeem, Lucas Hendrik, Raffaelli, Bianca, Mecklenburg, Jasper, Kelderman, Tim, Neeb, Lars, Reuter, Uwe
Gepubliceerd in 2021Text -
15
-
16
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention door Sacco, Simona, Bendtsen, Lars, Ashina, Messoud, Reuter, Uwe, Terwindt, Gisela, Mitsikostas, Dimos-Dimitrios, Martelletti, Paolo
Gepubliceerd in 2019Text -
17
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention door Sacco, Simona, Bendtsen, Lars, Ashina, Messoud, Reuter, Uwe, Terwindt, Gisela, Mitsikostas, Dimos-Dimitrios, Martelletti, Paolo
Gepubliceerd in 2019Text -
18
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study door Raffaelli, Bianca, Kalantzis, Rea, Mecklenburg, Jasper, Overeem, Lucas Hendrik, Neeb, Lars, Gendolla, Astrid, Reuter, Uwe
Gepubliceerd in 2020Text -
19
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study door Raffaelli, Bianca, Terhart, Maria, Overeem, Lucas Hendrik, Mecklenburg, Jasper, Neeb, Lars, Steinicke, Maureen, Reuter, Uwe
Gepubliceerd in 2021Text -
20
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs door Vandervorst, Fenne, Van Deun, Laura, Van Dycke, Annelies, Paemeleire, Koen, Reuter, Uwe, Schoenen, Jean, Versijpt, Jan
Gepubliceerd in 2021Text